Latest News- Automated Breast Ultrasound Systems (ABUS) Market: Diagnostic centers is expected to lead the End-user segment during 2024-2028

The Automated Breast Ultrasound Systems (ABUS) Market is being driven by Increasing demand for breast imaging products owing to the growing prevalence of breast cancer cases

The Automated Breast Ultrasound Systems (ABUS) Market is expected to grow at a CAGR of 14.8% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 666.5 million. In the competitive Automated Breast Ultrasound Systems (ABUS) market, companies are investing heavily in research and development to create technologically superior products. Securing adequate funding is crucial for bringing these innovative solutions to fruition. For instance, QT Imaging Inc., a privately held company specializing in the field, successfully raised capital for the development of its groundbreaking automated breast imaging system. The QTscan, QT Imaging's flagship product, offers high-resolution transmission ultrasound images without radiation, compression, or injections. In February 2019, the FDA granted the company a 510(K) clearance for this revolutionary technology, further solidifying its position in the market. 

Get more information on Automated Breast Ultrasound Systems (ABUS) Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on segments_for_ai.nslist

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing demand for breast imaging products owing to the growing prevalence of breast cancer cases
• Focus on early diagnosis and preventive medicine
• Integration of Artificial Intelligence (AI) into Ultrasound

However, the market also witnesses some limitations, which are as follows:

• Software corruption in ultrasound machines
• High cost of ABUS scanning and presence of low-cost alternatives
• Lack of knowledge and low adoption of ABUS

Benefits of Buying Global Automated Breast Ultrasound Systems (ABUS) Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Automated Breast Ultrasound Systems (ABUS) Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Automated Breast Ultrasound Systems (ABUS) have emerged as a valuable screening tool in the early detection of Breast Lesions and Cancer, particularly for women with dense breast tissue or those with mammographically occult cancers. Utilizing High-Frequency Sound Waves, these systems generate 3D Monochromatic Images, enabling Skilled Radiologists to better distinguish between benign and malignant lesions. The increasing Breast Cancer Incidence, driven by Sedentary Lifestyle, Obesity, Smoking, and Alcohol consumption, necessitates the need for Early Detection through various screening methods. ABUS complements Mammography, providing a non-ionizing alternative for Digital Cancer Screening. Computer-aided detection, Fusion imaging, and AI-based solutions further enhance the diagnostic accuracy of these systems. Transducer technology allows for improved visualization of Fatty Tissues and breast structures, making ABUS a crucial component of Preventative Care and Cancer Detection. Diagnostics imaging laboratories and Radiologists are increasingly adopting wearable ultrasound devices and 3D imaging techniques to streamline workflows and enhance patient care.

Market Research Overview

The Automated Breast Ultrasound Systems (ABUS) market is a significant segment within the expansive global healthcare equipment industry. This sector focuses on the production of advanced diagnostic tools, including ABUS, which utilize high-frequency sound waves to generate 3D monochromatic images of breast lesions. With the rising incidence of breast cancer due to sedentary lifestyles and obesity, the demand for ABUS systems is escalating. Technavio, a leading market research firm, includes the ABUS market in its comprehensive analysis of the global healthcare equipment market. This market encompasses manufacturers of capital equipment, instruments, implants, accessories, and consumables employed for disease diagnosis, monitoring, and treatment. The global healthcare equipment market size is determined by the combined revenue generated by these entities.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/